Sangamo BioSciences | SGMO - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Alaunos Therapeutics USD 5M 5M 2025-09
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Alterity Therapeutics Limited AUD 40M 16M 2026-05
Amgen USD 189.89B 13.64B 2026-03
Bayer EUR 37.69B 1.01B 2026-05
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.18B 683M 2026-05
Cipla INR 1.15T 162.77B 2026-05
Clal Biotechnology ILS 43.45M 8.92M 2026-03
Compugen USD 144.67M 7.17M 2025-12
CSL USD 55.89B 20.42B 2025-12
Gilead Sciences USD 167.39B 5.6B 2026-05
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
J&J USD 579.15B 78.91B 2026-03
Karyopharm Therapeutics USD 956M 821M 2026-05
Merck USD 297.1B 35.84B 2026-03
Novartis USD 232.75B 75B 2026-05
Pfizer USD 147.4B 6.42B 2026-05
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03
Sarepta Therapeutics USD 2.16B 123M 2026-05
Tectonic Therapeutic USD 390M 96M 2025-12
Ultragenyx Pharmaceutical USD 2.06B 1000K 2026-05
Vertex Pharmaceuticals USD 113.58B 1000K 2026-05